Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks King
They put out an email, which I unfortunately deleted, that updated the shareholders.
If anyone out there is a subscriber to their email, please post it.
They have raised funds to take them into 2016,( @ .03 @ share with warrants) Expect release of Neo"s Prostate test first QTR 2016, or sooner. SVM Capital software out performed the market during the big selloff...is going traction wit Hedge Funds .
I'll call them and see if they will resend the email.
How about TAC are they still under CAD authorities scrutiny are they a good buy yet?
http://www.transalta.com
A2-73 is not like the drugs you are thinking of. These new molecules are closer to the natural function in cell metabolism, very outside the pharmacological box of the past.
Read these publications to start:
http://www.anavex.com/files/Anavex_Presentation_May_2015.pdf
http://www.alzforum.org/news/conference-coverage/zuers-alpha-beta-sigma-which-will-yield-new-ad-drug
No effect on Baltia because they fly out off NYC Good Old USA where the economy is better than any other in the world and the Dollar has power. Plenty of Passengers with Buying Power.
Calls and Puts are options issued by the OCC and traded on an exchange like the COBE . The warrants are issued by the company as an inducement to Private Placement investors. Baltia's warrants are non tradable on any market but are redeemable by the company.
Option are usually traded on listed companies or some that are owned by institutions.
This is COBE's free education on Options:
http://www.investopedia.com/study-guide/series-4/options-market-place/option-clearing-corporation/
http://www.cboe.com/data/settlement.aspx
http://www.cboe.com/apps/default.aspx
BLtia has no options. However they do have non-tradable warrants.
Russia's growth @15%:..... Third best performing market of 2015....
http://humanevents.com/2015/09/01/how-the-brics-came-down-to-earth/
..Here’s the biggest surprise. Despite the pullback in recent months, Russia is up 14.97% for 2015. That makes it the third-best-performing market of 2015 among the 47 markets I track at my firm, Global Guru Capital. NOTE: Global Guru Capital is a Securities and Exchange Commission-registered investment adviser and is not affiliated with Eagle Financial Publications......
'maverick one' thanks for the heads up will look into it!!
I'm in BLTA for a long time also, but have averaged down so as not to miss the big part of the ride up.
That no doubt will be very soon, I feel it's as inevitable as any human venture this complex can be.
62.5% savings in JP fuel= $27,500,000 today's prices vs $4.00 then =up the bottomline to $44,000,000 net. Not bad for a little old penny stock!
Beautiful post tom123, thank you!
Sence my cost is very near the market price my per share cost would be 1000 x .0042 = $4.20 for a fully certified Air carrier with an exclusive nonstop route to St Pete. Because they will not RS till they certify and have multiple aircraft and routes working. A 1000 for 1 would make OS 6,000,000...a Market Cap of $240,000,000 very low for an airline producing $100M plus in rev. .
You are right. if you believe Baltia will be successful, as I do, then you need to accumulate more of the Baltia pie, as it is of necessity being divided into smaller units, till Baltia moves through this phase. That way you maintain or even increase your share of Americas Newest Airline. Like LT who now is one of Baltia's largest shareholder.
It seems negative but in the context of his over all projection, its just his fear of loss, and opinion. AVXL's Science is so compelling it is defying the fear that would drive it down; to those who give weight to the science, sell offs are buy points.
The chart is just a record of buy and sell points, It reflects market participants opinion, fear, greed at certain price points. Presumably they will repeat those sentiments. It also maybe nothing more than Vudoo but so many people follow the chart action that you must give some level of weight to it.
I also hold a very large position, believe in the science...and we should be many dollars above the currant price. Good fortune to you and all AVXL longs. If displaying past action scares people they shouldn't play in the OTC. They need to buy Blue Chip Dividend stocks.
I like to think news drives the price; however, substantive news cannot be released on a daily basis ..the chart reflects market action, TA attempts to explain what the market participants have done over any given period of time, including time between news releases. It also attempts to define accumulation distribution points that suggest market participants' past action in those areas will repeat. News will trump it all of course, but the past actions, Neg or Pos can be anticipated, though not perfectly.
123tom's post that show his full assessment of AVXL:
This post was when the stock was testing its highs. Notice he explained the wave theory that could, in wave 5, take the price above $1.70, $2.50, and target of $4.50
123tom: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116386201
But before it begins a Wave 5 rally...it needs to finish the sideways Range of a Wave 4...Its possible we are seeing a zig zag sideways wave 4 developing...and this big volatile zone from 1 dollar to 1.67 could go back and forth a few more times.
The Posts below are subsequent to the price Top. Maybe you missed prior post and are reading his comment of the sell off wave 4, and interpret it as negative, but his charts have been pinpoint accurate so far.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116417902
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116526609
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116526366
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116452298
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116451793
I don't think he is negatively biased, as he stated the charts lay out the numbers as probabilities. That includes the upside as well as the downside. If one fears the downside one will focus on down data points rather then the up data points. He definitely includes both.
The present price only offers an opportunity, because we know any press release of substance, which is inevitable, will light a fire under the price.
OIL could see a $20.00 handle! great for BLTA.
I think the market is waiting for a news on their blockbusters genomic test coming last half this or 1st. Of 2016
So far we are holding our support while All other sectors are down.
Enjoying Here Boss!
No gap,.. The after market on Tuesday saw a price $1.51 @ >300K shares traded, Wednesday the Pre market $1.50 to $1.52 about 40K traded. So the open had that steam left over from Tuesday.
Right it larger amount was post market 08/18/15
Looks like 867k in permarket $1.51
It is not toxic only dilutive , born out of necessity, but your protection is to grab even larger pieces of the pie. The PP share are Baltia Saints who keep the company in the hunt for Cert.
O&W I've bought so many lately I'm near the Market Price. Hope to scoop up more shortly .
You must wait 6 months Plus to sell PP shares. Most of the PP share are losing money today, Now is the time to buy Market share that can be sold the same day if you wish, a no brainer!
It should be apparent to all that the Baltia is in the hunt for certification, the sensible thing here is to accumulate as many shares at cheap prices to survive to completion and the continuing need to dilute the share structure till we Certify. The Only question is when will we Cert not IF and will you be along to the finish with a reasonable average?
Any wise investors that believes Baltia will eventually succeed needs to step up and buy heavily at these prices because you have a small window of opportunity to get the shares at prices previously only available to PP....and it will bring your average down to match PP share holders. I've done PP with Baltia and now am buying in the Market it is phenomenal how my average has come down. Also this protects your investment.
These low prices are way below Most PP shares, Any new PP shares have to wait 6 months to sell, The sub penny trading started about April and it takes weeks to register and deposit those subpennies; therefore, it is not likely PP shares, but most likely the market makers naked selling to provide liquidity, a standard practice when there are limited share available....This is bornout when you see the shorting stats.
Look What Institution Opened a Position in CTIX:
http://www.nasdaq.com/symbol/ctix/institutional-holdings
One PLACE find Institutional ownership:
http://www.nasdaq.com/symbol/ctix/institutional-holdings
conf call
Unidentified Analyst
Hi, this is [Kevin Watos] [ph] speaking for Ritu Baral. With respect to BPS/IC, how does this data compare to the Elmiron's data?
David Main - President, Chief Executive Officer
We always have to be cautious in making that comparison because of course this is not a randomized controlled trial comparing the two drugs. But from everything that we can see, we believe that it compares very favorably. Probably what's most important about the data that’s being reported about Elmiron, is it's very contradictory. Really on the earliest studies showed a benefit of Elmiron and fairly modestly over placebo. Most of the subsequent trials have shown no advantage over a placebo.
So again, I always want to be cautious, we haven't done that direct comparison. But we feel very confident that this is a very favorable comparison of the data we had generated in a very rigorous trial to that’s what's been reported for Elmiron.
8K/a
Announced Encouraging Results from LEADERSHIP, a Phase 2 clinical trial of AQX-1125 in bladder pain syndrome/interstitial cystitis (BPS/IC). Aquinox reported top line results from its LEADERSHIP trial on June 25, 2015 did not reach statistical significance in its primary endpoint, but did demonstrate an encouraging trend in pain reduction for patients treated with AQX-1125 compared to placebo. The LEADERSHIP trial also demonstrated a high proportion of patients (49%) having achieved a clinically meaningful improvement in pain (2 points or greater on an 11-point NRS scale) as compared to placebo (34%)
Thanks My thoughts also, smells like short covering.
I'm constantly seeing Large blocks, 50K to over 100K appearing near support from several MM's, so is it accumulation for there inventory or are they accumulating for the warrant holders?
Does AVXL have a Market Maker? and Who is it? Could it be short covering?
CANT HAS 162500@$1.30 BID